MADRIGAL PHARMACEUTICALS, INC. Increase (Decrease) in Other Noncurrent Assets
MADRIGAL PHARMACEUTICALS, INC. (MDGL) reported Increase (Decrease) in Other Noncurrent Assets of -$305.00 thousand for the 12-month period ending 2015-12-31, per its 10-K filed 2016-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2016-07-20
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2015-12-31 was -$226.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2015-09-30 was -$52.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2015-06-30 was -$286.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2015-03-31 was $259.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2015 was -$305.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2014 was -$111.00K, a 111.67% decline from fiscal 2013.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2013 was $951.00K.
- MADRIGAL PHARMACEUTICALS, INC. increase (decrease) in other noncurrent assets for fiscal 2012 was -$173.00K, a 165.28% decline from fiscal 2011.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2015-12-31 | -$226.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$278.00K derived: sum of 2 quarters · filed 2016-03-15 | -$564.00K derived: sum of 3 quarters · filed 2016-07-20 | -$305.00K 10-K · filed 2016-03-15 |
| 2015-09-30 | -$52.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$338.00K derived: sum of 2 quarters · filed 2016-07-20 | -$79.00K 10-Q · filed 2015-11-05 | -$105.00K derived: sum of 4 quarters · filed 2016-07-20 |
| 2015-06-30 | -$286.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-20 | -$27.00K 10-Q · filed 2016-07-20 | -$53.00K derived: sum of 3 quarters · filed 2016-07-20 | -$80.00K derived: sum of 4 quarters · filed 2016-07-20 |
| 2015-03-31 | $259.00K 10-Q · filed 2016-05-10 | $233.00K derived: sum of 2 quarters · filed 2016-05-10 | $206.00K derived: sum of 3 quarters · filed 2016-05-10 | $180.00K derived: sum of 4 quarters · filed 2016-05-10 |
| 2014-12-31 | -$26.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | -$53.00K derived: sum of 2 quarters · filed 2016-03-15 | -$79.00K derived: sum of 3 quarters · filed 2016-03-15 | -$111.00K 10-K · filed 2016-03-15 |
| 2014-09-30 | -$27.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-05 | -$53.00K derived: sum of 2 quarters · filed 2015-11-05 | -$85.00K 10-Q · filed 2015-11-05 | $891.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-06 | -$58.00K 10-Q · filed 2015-08-06 | $918.00K derived: sum of 3 quarters · filed 2016-03-15 | $887.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2014-03-31 | -$32.00K 10-Q · filed 2015-05-07 | $944.00K derived: sum of 2 quarters · filed 2016-03-15 | $913.00K derived: sum of 3 quarters · filed 2016-03-15 | $896.00K derived: sum of 4 quarters · filed 2016-03-15 |
| 2013-12-31 | $976.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-15 | $945.00K derived: sum of 2 quarters · filed 2016-03-15 | $928.00K derived: sum of 3 quarters · filed 2016-03-15 | $951.00K 10-K · filed 2016-03-15 |
| 2013-09-30 | -$31.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$48.00K derived: sum of 2 quarters · filed 2014-11-06 | -$25.00K 10-Q · filed 2014-11-06 | -$33.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-06-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-06 | $6.00K 10-Q · filed 2014-08-06 | -$2.00K derived: sum of 3 quarters · filed 2015-03-12 | -$39.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2013-03-31 | $23.00K 10-Q · filed 2014-05-08 | $15.00K derived: sum of 2 quarters · filed 2015-03-12 | -$22.00K derived: sum of 3 quarters · filed 2015-03-12 | -$38.00K derived: sum of 4 quarters · filed 2015-03-12 |
| 2012-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | -$45.00K derived: sum of 2 quarters · filed 2015-03-12 | -$61.00K derived: sum of 3 quarters · filed 2015-03-12 | -$173.00K 10-K · filed 2015-03-12 |
| 2012-09-30 | -$37.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-04 | -$53.00K derived: sum of 2 quarters · filed 2013-11-04 | -$165.00K 10-Q · filed 2013-11-04 | -$64.00K derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-06-30 | -$16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-01 | -$128.00K 10-Q · filed 2013-08-01 | -$27.00K derived: sum of 3 quarters · filed 2014-03-11 | $6.00K derived: sum of 4 quarters · filed 2014-03-11 |
| 2012-03-31 | -$112.00K 10-Q · filed 2013-04-30 | -$11.00K derived: sum of 2 quarters · filed 2014-03-11 | $22.00K derived: sum of 3 quarters · filed 2014-03-11 | $102.00K derived: sum of 4 quarters · filed 2014-03-11 |
| 2011-12-31 | $101.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $134.00K derived: sum of 2 quarters · filed 2014-03-11 | $214.00K derived: sum of 3 quarters · filed 2014-03-11 | $265.00K 10-K · filed 2014-03-11 |
| 2011-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | $113.00K derived: sum of 2 quarters · filed 2012-11-06 | $164.00K 10-Q · filed 2012-11-06 | $69.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-06-30 | $80.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | $131.00K 10-Q · filed 2012-08-02 | $36.00K derived: sum of 3 quarters · filed 2013-03-14 | $346.00K derived: sum of 4 quarters · filed 2013-03-14 |
| 2011-03-31 | $51.00K 10-Q · filed 2012-05-03 | -$44.00K derived: sum of 2 quarters · filed 2013-03-14 | $266.00K derived: sum of 3 quarters · filed 2013-03-14 | |
| 2010-12-31 | -$95.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14 | $215.00K derived: sum of 2 quarters · filed 2013-03-14 | $8.00K 10-K · filed 2013-03-14 | |
| 2010-09-30 | $310.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-03 | $103.00K 10-Q · filed 2011-11-03 | ||
| 2010-06-30 | -$207.00K 10-Q · filed 2011-08-04 | |||
| 2009-12-31 | $255.00K 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |